Change for systemic fluroquinolone class of antibacterial drugs: Refer to http://www.accessdata.fda.gov/scripts/cder/safetyla belingchanges/?source=govdelivery&utm_medium=email&utm_source=govdelivery for specific NDA:
Avelox (moxifloxacin hydrochloride), Avelox in sodium chloride 0.8% in plastic container, Cipro (ciprofloxacin; ciprofloxacin hydrochloride), Cipro in dextrose 5% in plastic container, Cipro XR (ciprofloxacin; ciprofloxacin hydrochloride), Factive (gemifloxacin mesylate), Levaquin (levofloxacin), moxifloxacin hydrochloride, Noroxin (norfloxacin) 
Updated Quinolone Boxed Warning

Plavix (clopidogrel bisulfate)
Edited Boxed Warning
WARNING: DIMINISHED ANTIPLATELET EFFECT IN PATIENTS WITH TWO LOSS-OF-FUNCTION ALLELES OF THE CYP2C19 GENE
The effectiveness of Plavix results from its antiplatelet activity, which is dependent on its conversion to an active metabolite by the cytochrome P450 (CYP) system, principally CYP2C19. Plavix at recommended doses forms less of the active metabolite and so has a reduced effect on platelet activity in patients who are homozygous for nonfunctional alleles of the CYP2C19 gene (termed "CYP2C19 poor metabolizers"). Tests are available to identify patients who are CYP2C19 poor metabolizers. Consider use of another platelet P2Y12 inhibitor in patients identified as CYP2C19 poor metabolizers.
Synjardy (empagliflozin; metformin hydrochloride)
WARNING: LACTIC ACIDOSIS
Postmarketing cases of metformin-associated lactic acidosis have resulted in death, hypothermia, hypotension, and resistant bradyarrhythmias. The onset of metformin-associated lactic acidosis is often subtle, accompanied only by nonspecific symptoms such as malaise, myalgias, respiratory distress, somnolence, and abdominal pain. Metformin-associated lactic acidosis was characterized by elevated blood lactate levels (>5 mmol/Liter), anion gap acidosis (without evidence of ketonuria or ketonemia), an increased lactate/pyruvate ratio, and metformin plasma levels generally >5 mcg/mL.
Risk factors for metformin-associated lactic acidosis include renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery and other procedures, hypoxic states (e.g., acute congestive heart failure), excessive alcohol intake, and hepatic impairment.
